<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000512986"><TermName>ProMune</TermName><TermPronunciation>(PROH-myoon)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of some types of cancer. It belongs to the family of drugs called biological response modifiers. Also called CpG 7909 and PF-3512676.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718407" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ProMune&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718406" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ProMune&quot;" language="es" id="_4"/><SpanishTermName>ProMune</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. Es un tipo de modificador de la respuesta biológica. También se llama CpG 7909 y PF-3512676.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-10-14</DateFirstPublished><DateLastModified>2006-10-12</DateLastModified></GlossaryTerm>
